2/24
08:33 am
legn
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results [Yahoo! Finance]
Medium
Report
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results [Yahoo! Finance]
2/24
08:00 am
legn
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results
Low
Report
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results
2/24
06:47 am
legn
Legend Biotech (NASDAQ:LEGN) was downgraded by analysts at Truist Financial Corporation from a "strong-buy" rating to a "hold" rating.
Medium
Report
Legend Biotech (NASDAQ:LEGN) was downgraded by analysts at Truist Financial Corporation from a "strong-buy" rating to a "hold" rating.
2/23
01:05 pm
legn
Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Medium
Report
Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
2/23
11:22 am
legn
Legend Biotech (LEGN) Valuation Check After Barclays Update And 2026 Profitability Targets [Yahoo! Finance]
Medium
Report
Legend Biotech (LEGN) Valuation Check After Barclays Update And 2026 Profitability Targets [Yahoo! Finance]
2/16
12:38 pm
legn
FDA Guidance on MRD Negativity Bodes Well for Legend Biotech (LEGN) [Yahoo! Finance]
Low
Report
FDA Guidance on MRD Negativity Bodes Well for Legend Biotech (LEGN) [Yahoo! Finance]
2/12
07:55 am
legn
Legend Biotech (NASDAQ:LEGN) was downgraded by analysts at Rothschild & Co Redburn from a "buy" rating to a "neutral" rating. They now have a $24.00 price target on the stock.
Low
Report
Legend Biotech (NASDAQ:LEGN) was downgraded by analysts at Rothschild & Co Redburn from a "buy" rating to a "neutral" rating. They now have a $24.00 price target on the stock.
2/7
03:48 am
legn
Legend Biotech (LEGN) Shakes Up Board [Yahoo! Finance]
Low
Report
Legend Biotech (LEGN) Shakes Up Board [Yahoo! Finance]
2/4
09:44 am
legn
Legend Biotech (NASDAQ:LEGN) had its price target lowered by analysts at Barclays PLC from $90.00 to $80.00. They now have an "overweight" rating on the stock.
Low
Report
Legend Biotech (NASDAQ:LEGN) had its price target lowered by analysts at Barclays PLC from $90.00 to $80.00. They now have an "overweight" rating on the stock.
2/3
11:33 am
legn
Legend Biotech (LEGN) Valuation Check After Recent Share Price Pullback [Yahoo! Finance]
Low
Report
Legend Biotech (LEGN) Valuation Check After Recent Share Price Pullback [Yahoo! Finance]
2/2
09:44 am
legn
H.C. Wainwright Highlight Curative Potential of Legend Biotech Corporation (LEGN)'s Carvykti Despite Sales Miss [Yahoo! Finance]
Low
Report
H.C. Wainwright Highlight Curative Potential of Legend Biotech Corporation (LEGN)'s Carvykti Despite Sales Miss [Yahoo! Finance]
1/29
08:01 am
legn
GenScript Biotech Global Forum, "Scripting Possibilities", Convened AI and Biopharma Leaders in San Francisco
Low
Report
GenScript Biotech Global Forum, "Scripting Possibilities", Convened AI and Biopharma Leaders in San Francisco
1/26
03:29 am
legn
Legend Biotech (LEGN) Advances Cell Therapy Innovation and Expands Oncology Pipeline [Yahoo! Finance]
Low
Report
Legend Biotech (LEGN) Advances Cell Therapy Innovation and Expands Oncology Pipeline [Yahoo! Finance]
1/23
07:32 am
legn
Legend Biotech: Carvykti Driving Growth Amid FDA Regulatory Tailwinds [Seeking Alpha]
Low
Report
Legend Biotech: Carvykti Driving Growth Amid FDA Regulatory Tailwinds [Seeking Alpha]
1/22
08:06 am
legn
Legend Biotech (NASDAQ:LEGN) had its price target lowered by analysts at HC Wainwright from $60.00 to $50.00. They now have a "buy" rating on the stock.
Medium
Report
Legend Biotech (NASDAQ:LEGN) had its price target lowered by analysts at HC Wainwright from $60.00 to $50.00. They now have a "buy" rating on the stock.
1/22
03:02 am
legn
Legend Biotech (NASDAQ:LEGN) was given a new $21.00 price target on by analysts at Jefferies Financial Group Inc..
Medium
Report
Legend Biotech (NASDAQ:LEGN) was given a new $21.00 price target on by analysts at Jefferies Financial Group Inc..
1/21
10:06 pm
legn
Legend Biotech (NASDAQ:LEGN) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating.
Medium
Report
Legend Biotech (NASDAQ:LEGN) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating.
1/21
08:00 am
legn
Legend Biotech to Present CARVYKTI® Data at 2026 Tandem Meetings Reinforcing Growing Evidence Supporting Earlier Use
High
Report
Legend Biotech to Present CARVYKTI® Data at 2026 Tandem Meetings Reinforcing Growing Evidence Supporting Earlier Use
1/20
03:13 pm
legn
Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
1/20
12:47 pm
legn
Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $66.00 price target on the stock.
Neutral
Report
Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $66.00 price target on the stock.
1/20
06:59 am
legn
Legend Biotech (NASDAQ:LEGN) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
Medium
Report
Legend Biotech (NASDAQ:LEGN) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
1/12
08:55 am
legn
Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/12
08:00 am
legn
Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference
1/9
12:27 pm
legn
Cantor Fitzgerald and RBC Capital Stay Bullish on Legend Biotech (LEGN) [Yahoo! Finance]
Low
Report
Cantor Fitzgerald and RBC Capital Stay Bullish on Legend Biotech (LEGN) [Yahoo! Finance]
1/9
04:31 am
legn
Why The Legend Biotech LEGN Story Is Shifting As Carvykti And Competition Reframe Expectations [Yahoo! Finance]
Low
Report
Why The Legend Biotech LEGN Story Is Shifting As Carvykti And Competition Reframe Expectations [Yahoo! Finance]